首页> 外文期刊>Cureus. >The Value of Adding Red Cell Distribution Width to Mehran Risk Score to Predict Contrast-induced Acute Kidney Injury in Patients with Acute Coronary Syndrome
【24h】

The Value of Adding Red Cell Distribution Width to Mehran Risk Score to Predict Contrast-induced Acute Kidney Injury in Patients with Acute Coronary Syndrome

机译:在Mehran风险评分中增加红细胞分布宽度以预测急性冠状动脉综合征患者的造影剂诱发的急性肾损伤的价值

获取原文
           

摘要

Background: Contrast-induced acute kidney injury (CI-AKI) is a relatively reversible cause of acute kidney injury (AKI) that occurs after radiocontrast media administration. It is a common complication after percutaneous coronary intervention, especially in patients with acute coronary syndrome (ACS). The aim of this study is to determine the utility of red cell distribution width (RDW) in predicting CI-AKI in patients with ACS and to determine the value of adding RDW to the Mehran risk score (MRS) on admission. Methods: A total of 161 patients who presented with ST-elevation myocardial infarction (STEMI) or non-STEMI were identified retrospectively between January 2015 and December 2016. Patients were divided into two groups, those who developed CI-AKI after percutaneous coronary intervention (PCI) and those who did not. Results: A total of 161 patients were analyzed. Of them, 12 developed CI-AKI (eight presented with STEMI?and four presented with non-STEMI). RDW did not correlate with the development of CI-AKI (14.55 ± 1.48 vs 14.83 ± 1.21; p = 0.072). The areas under the receiver operating characteristic curves (ROCs) for RDW, MRS, and the combined model (MRS and RDW) for the prediction of CI-AKI were 0.721 (95% confidence interval (CI), 0.645 to 0.788; p=0.0024), 0.885 (95% CI, 0.825 to 0.930; p0.0001), 0.890 (95% CI, 0.831 to 0.933; p0.0001), respectively. Pairwise comparisons between ROCs for MRS vs the combined model yielded a non-significant p-value of 0.49. This signifies no added benefit for RDW to MRS for predicting CI-AKI. Conclusion: RDW does not?correlate with the development of CI-AKI in patients with ACS. The Mehran risk score remains a better indicator of CI-AKI risk assessment with no role for the addition of RDW to it. Further studies are needed to better assess predictors of CI-AKI in patients undergoing?percutaneous coronary intervention.
机译:背景:造影剂引起的急性肾损伤(CI-AKI)是放射性造影剂给药后发生的相对可逆的急性肾损伤(AKI)原因。这是经皮冠状动脉介入治疗后的常见并发症,尤其是在急性冠脉综合征(ACS)患者中。这项研究的目的是确定红细胞分布宽度(RDW)在预测ACS患者CI-AKI中的作用,并确定入院时将RDW添加到Mehran风险评分(MRS)中的价值。方法:回顾性分析2015年1月至2016年12月间共161例患有ST抬高型心肌梗死(STEMI)或非STEMI的患者。将患者分为两组,经皮冠状动脉介入治疗后发生CI-AKI( PCI)和那些没有的人。结果:共分析161例患者。其中,有12台开发的CI-AKI(其中8台使用STEMI ?,四台使用非STEMI)。 RDW与CI-AKI的发展无相关性(14.55±1.48对14.83±1.21; p = 0.072)。预测CI-AKI的RDW,MRS和组合模型(MRS和RDW)的接收器工作特征曲线(ROC)下的面积为0.721(95%置信区间(CI),0.645至0.788; p = 0.0024) ),0.885(95%CI,0.825至0.930; p <0.0001),0.890(95%CI,0.831至0.933; p <0.0001)。 MRS的ROC与组合模型之间的成对比较得出非显着的p值为0.49。这表示RDW对MRS预测CI-AKI没有任何额外的好处。结论:RDW与ACS患者的CI-AKI发展无关。 Mehran风险评分仍然是CI-AKI风险评估的更好指标,并且不添加RDW。需要进行进一步的研究以更好地评估经皮冠状动脉介入治疗患者中CI-AKI的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号